DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00404170 (ClinicalTrials.gov)	November 2006	22/11/2006	Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease	Assessing the Determinants of PD Progression - Long-term Dopamine Transporter Imaging in the PRECEPT Cohort	Parkinson Disease	Drug: B-CIT and SPECT imaging	Institute for Neurodegenerative Disorders	United States Department of Defense	Completed	30 Years	N/A	All	396	Phase 2	United States
2	NCT00096720 (ClinicalTrials.gov)	February 2004	12/11/2004	Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease	Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's	Parkinson Disease;Parkinsonian Syndrome	Drug: levodopa;Drug: Mirapex (pramipexole);Procedure: [123I]ß-CIT and SPECT imaging	Institute for Neurodegenerative Disorders	Boehringer Ingelheim;Department of Defense	Completed	30 Years	N/A	Both	112	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00404170
(ClinicalTrials.gov)

November 2006

22/11/2006

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

Assessing the Determinants of PD Progression - Long-term Dopamine Transporter Imaging in the PRECEPT Cohort

Parkinson Disease

Drug: B-CIT and SPECT imaging

Institute for Neurodegenerative Disorders

United States Department of Defense

Completed

30 Years

N/A

All

396

Phase 2

United States

NCT00096720
(ClinicalTrials.gov)

February 2004

12/11/2004

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's

Parkinson Disease;Parkinsonian Syndrome

Drug: levodopa;Drug: Mirapex (pramipexole);Procedure: [123I]ß-CIT and SPECT imaging

Institute for Neurodegenerative Disorders

Boehringer Ingelheim;Department of Defense

Completed

30 Years

N/A

Both

112

Phase 2

United States